首页/数据集/Overview of key change in India’s clinical trial regulations.

Overview of key change in India’s clinical trial regulations.

Figshare2019-01-03 更新2026-04-29 收录

临床试验监管

医药法规政策

数据链接：

https://figshare.com/articles/dataset/Overview_of_key_change_in_India_s_clinical_trial_regulations_/7544204 数据链接链接失效反馈

官方服务：

资源简介：

Overview of key change in India’s clinical trial regulations.

应用场景：

创建时间：

2019-01-03

相关数据集

Clinical Investigator Inspection List

药物临床试验

临床试验监管

The Clinical Investigator Inspection List (CLIIL) contains names, addresses, and other pertinent information gathered from inspections of clinical investigators who have performed studies with investi

www.johnsnowlabs.com290

For 51 pivotal trials, a comparison of the phase information in the FDA’s MedR documents and in ClinicalTrials.gov (CTG).

临床试验监管

药物研发数据

For 51 pivotal trials, a comparison of the phase information in the FDA’s MedR documents and in ClinicalTrials.gov (CTG).

NIAID Data Ecosystem40

Table_8_In India, most principal investigators have run very few trials over the years.XLSX

临床试验监管

研究者绩效评估

BackgroundIn the past, clinical trials run in India have been the subject of criticism. Among other steps to improve the trial ecosystem, for some time the government limited the number of trials that

NIAID Data Ecosystem20

Data set of primary outcome changes in interventional clinical trials registered on ClinicalTrials.org

临床试验结局变更

临床试验监管

All clinical studies classified as ‘interventional studies’ registered with ClinicalTrials as of 25 October 2012 are shown. The following information was collected from each study: study registration

NIAID Data Ecosystem70

Areas of clinical trial conduct where overly cautious application of guidelines (“guideline application creep”) might be problematic.

临床试验监管

指南应用偏差

DSMB, data safety and monitoring board.

Figshare2015-12-02 更新30